ArticleTherapeutic advances in endocrinology and metabolism2026

GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease.

No numbers read from the abstract.

Not cited yet